ストックスクリーナーアプリを入手
21.54
3.75%
-0.84
アフターアワーズ：
21.67
0.13
+0.60%
Cidara Therapeutics Inc (CDTX) 最新ニュース
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Significant Increase in Short Interest - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Bourla becomes chair of PhRMA - BioCentury
Invasive Candidiasis Market to Reach New Heights in Growth - openPR
Brokerages Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) Price Target at $32.20 - Defense World
Cidara Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective February 24, 2025 - Marketscreener.com
Cidara CFO steps down, new appointment announced By Investing.com - Investing.com South Africa
Cidara Therapeutics Announces Appointment Of Frank Karbe As Chief Financial Officer - Marketscreener.com
Cidara Therapeutics Announces CFO Transition - TipRanks
Cidara CFO steps down, new appointment announced - Investing.com
Cidara Therapeutics appoints new CFO amid flu drug trials - Investing.com India
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer - GlobeNewswire
Strategic CFO Hire: $4B Deal Architect Frank Karbe Joins Cidara as Growth Plans Accelerate - StockTitan
Cidara Therapeutics (NASDAQ:CDTX) Stock Price Crosses Above Fifty Day Moving AverageHere's What Happened - MarketBeat
Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention - Seeking Alpha
(CDTX) Trading Signals - Stock Traders Daily
Cidara Therapeutics (NASDAQ:CDTX) Stock Rating Upgraded by Cantor Fitzgerald - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Up 113.6% in January - MarketBeat
Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire
Inside Cidara's Next Move: CEO Jeffrey Stein Takes Center Stage at Elite Biotech Conference - StockTitan
Long Term Trading Analysis for (CDTX) - Stock Traders Daily
Cantor Fitzgerald raises Cidara stock to Overweight - MSN
Cidara Therapeutics’ (CDTX) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Cantor Fitzgerald raises Cidara stock to Overweight By Investing.com - Investing.com Canada
Cidara Therapeutics (NASDAQ:CDTX) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Cidara Therapeutics (NASDAQ:CDTX) Share Price Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives $32.20 Consensus Price Target from Analysts - MarketBeat
Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Kodiak Sciences (NASDAQ:KOD) - Defense World
Here’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing - MSN
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Update - MarketBeat
Why These 24 Stocks Are Skyrocketing - Insider Monkey
Geode Capital Management LLC Buys 9,771 Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World
(CDTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Cidara Therapeutics (NASDAQ:CDTX) Shares Cross Above 50 Day Moving AverageTime to Sell? - MarketBeat
Cidara Therapeutics announces board changes, CMO separation - Investing.com
Cidara Therapeutics Announces Leadership Changes and Appointments - MSN
Cidara Therapeutics, Inc. Announces Management Changes - Marketscreener.com
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):